196 related articles for article (PubMed ID: 36517235)
1. Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T; Katayama Y; Hiasa Y; Nishihara M; Tajima F; Katoh S; Tanaka H; Maeda T; Furusawa K; Richardson M; Kakehi Y; Kikumori K; Kuroha M
Neurology; 2023 Mar; 100(11):e1193-e1206. PubMed ID: 36517235
[TBL] [Abstract][Full Text] [Related]
2. Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study.
Baba M; Kuroha M; Ohwada S; Murayama E; Matsui N
Pain Ther; 2020 Jun; 9(1):261-278. PubMed ID: 32052264
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.
Kato J; Baba M; Kuroha M; Kakehi Y; Murayama E; Wasaki Y; Ohwada S
Clin Ther; 2021 May; 43(5):822-835.e16. PubMed ID: 34059327
[TBL] [Abstract][Full Text] [Related]
4. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain.
Guo X; Yu Y; Zhang Y; Sun L; Li Y; Song B; Hang L; Baba M; Wasaki Y; Kikumori K; Murayama E
Pain Ther; 2024 Jun; ():. PubMed ID: 38896199
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia.
Ushida T; Katayama Y; Hiasa Y; Nishihara M; Tajima F; Katoh S; Tanaka H; Maeda T; Furusawa K; Kakehi Y; Kikumori K; Kuroha M
Pain Ther; 2023 Aug; 12(4):963-978. PubMed ID: 37115464
[TBL] [Abstract][Full Text] [Related]
6. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.
Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
J Diabetes Investig; 2019 Sep; 10(5):1299-1306. PubMed ID: 30672128
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.
Vinik A; Rosenstock J; Sharma U; Feins K; Hsu C; Merante D;
Diabetes Care; 2014 Dec; 37(12):3253-61. PubMed ID: 25231896
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study.
Merante D; Rosenstock J; Sharma U; Feins K; Hsu C; Vinik A;
Pain Med; 2017 Nov; 18(11):2198-2207. PubMed ID: 28371941
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial.
Kato J; Matsui N; Kakehi Y; Murayama E; Ohwada S
Medicine (Baltimore); 2020 Sep; 99(36):e21976. PubMed ID: 32899037
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study.
Nikaido T; Takatsuna H; Tabata S; Shiosakai K; Nakatani T; Konno SI
Pain Ther; 2022 Dec; 11(4):1195-1214. PubMed ID: 35857196
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.
Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK
Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain.
Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
J Diabetes Investig; 2020 May; 11(3):693-698. PubMed ID: 31722446
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Mirogabalin in Central Neuropathic Pain After Stroke: Post Hoc Analysis of a Phase 3 Study by Stroke Type and Location.
Hosomi K; Katayama Y; Sakoda H; Kikumori K; Kuroha M; Ushida T
Pain Ther; 2024 Jul; ():. PubMed ID: 38963656
[TBL] [Abstract][Full Text] [Related]
14. Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.
Baba M; Takatsuna H; Matsui N; Ohwada S
J Pain Res; 2020; 13():1811-1821. PubMed ID: 32765056
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study.
Arnold LM; Whitaker S; Hsu C; Jacobs D; Merante D
Curr Med Res Opin; 2019 Oct; 35(10):1825-1835. PubMed ID: 31284771
[No Abstract] [Full Text] [Related]
16. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury.
Cardenas DD; Nieshoff EC; Suda K; Goto S; Sanin L; Kaneko T; Sporn J; Parsons B; Soulsby M; Yang R; Whalen E; Scavone JM; Suzuki MM; Knapp LE
Neurology; 2013 Feb; 80(6):533-9. PubMed ID: 23345639
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
18. Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients.
Kato J; Matsui N; Kakehi Y; Murayama E; Ohwada S; Sugihara M
Pain; 2019 May; 160(5):1175-1185. PubMed ID: 30913164
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study.
Miyazaki T; Matsumoto K; Sato T; Sano I; Furukawa K; Shimoyama K; Kamohara R; Suzuki M; Kondou M; Ikeda N; Tabata S; Shiosakai K; Nagayasu T;
BMC Cancer; 2024 Jan; 24(1):80. PubMed ID: 38225552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
